









市场行情
/
股票
/
nasdaq-htfl
/

Heartflow Inc

HTFL

31.580USD

+1.070+3.51%

交易中（美东）报价延迟15分钟

2.64B总市值

亏损市盈率 TTM



Heartflow Inc

31.580

+1.070+3.51%

概览公司财务分析

概览

公司

财务

分析

关于 Heartflow Inc 公司

HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.

Heartflow Inc简介



公司代码HTFL

公司名称Heartflow Inc

上市日期Aug 08, 2025

CEOFarquhar (John C. M)

员工数量699

证券类型Ordinary Share

年结日Aug 08

公司地址331 E Evelyn Avenue

城市MOUNTAIN VIEW

上市交易所NASDAQ OMX - NASDAQ BASIC

国家United States of America

邮编94041

电话16502411221

网址https://www.heartflow.com/

公司代码HTFL

上市日期Aug 08, 2025

CEOFarquhar (John C. M)

Heartflow Inc公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Vikram Verghese

Chief Financial Officer

123.86K

-0.38%

Mr. Lonnie M. Smith

Independent Director

34.25K

Mr. Casey M. Tansey

Independent Director

16.45K

Dr. Campbell D. Rogers, M.D.

Chief Medical Officer

Mr. Tim Barabe

Independent Director

Ms. Julie Cullivan

Independent Director

Mr. Jeffrey C. Lightcap

Independent Director

Mr. William C. (Bill) Weldon

Independent Chairman of the Board

Dr. Wayne Riley, M.D.

Independent Director

Dr. Nicholas Downing, M.D.

Director

名称

名称/职务

职务

持股

持股变动

Mr. Vikram Verghese

Chief Financial Officer

123.86K

-0.38%

Mr. Lonnie M. Smith

Independent Director

34.25K

Mr. Casey M. Tansey

Independent Director

16.45K

Dr. Campbell D. Rogers, M.D.

Chief Medical Officer

Mr. Tim Barabe

Independent Director

Ms. Julie Cullivan

Independent Director

收入明细

由于公司未披露，未能获取相关数据

由于公司未披露，未能获取相关数据

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 11月30日周日

持股股东

股东类型

持股股东

占比

Bain Capital Life Sciences Investors, LLC

14.62%

HealthCor Partners Management LP

7.86%

Wellington Management Company, LLP

5.73%

Fidelity Management & Research Company LLC

5.42%

Capricorn Investment Group LLC

4.61%

其他

61.76%

持股股东

占比

Bain Capital Life Sciences Investors, LLC

14.62%

HealthCor Partners Management LP

7.86%

Wellington Management Company, LLP

5.73%

Fidelity Management & Research Company LLC

5.42%

Capricorn Investment Group LLC

4.61%

其他

61.76%

股东类型

持股股东

占比

Investment Advisor

53.56%

Investment Advisor/Hedge Fund

12.32%

Hedge Fund

3.14%

Individual Investor

2.47%

Endowment Fund

0.37%

Private Equity

0.18%

Pension Fund

0.14%

Research Firm

0.10%

Bank and Trust

0.08%

其他

27.65%

机构持股



更新时间: 9月12日周五

报告期

机构数

持股数

持股占比

持股变动

2025Q3

45.42M

54.46%

+42.91M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

Bain Capital Life Sciences Investors, LLC

12.45M

14.93%

+12.45M

Aug 08, 2025

HealthCor Partners Management LP

6.70M

8.03%

+6.70M

Aug 08, 2025

Wellington Management Company, LLP

4.41M

5.29%

+4.41M

Aug 08, 2025

Fidelity Management & Research Company LLC

3.29M

3.94%

+3.29M

Aug 08, 2025

Capricorn Investment Group LLC

3.92M

4.7%

+3.92M

Aug 08, 2025

Hayfin Capital Management LLP

3.64M

4.36%

+3.64M

Aug 08, 2025

The Vanguard Group, Inc.

1.17M

1.4%

+1.17M

Aug 31, 2025

持股ETF



更新时间: 12月6日周六

机构名称

占比

TrueShares Technology, AI & Deep Learning ETF

3.13%

Global X HealthTech ETF

1.75%

Fidelity Blue Chip Growth ETF

0.07%

T Rowe Price Small-Mid Cap ETF

0.06%

iShares Health Innovation Active ETF

0.02%

Schwab U.S. Small-Cap ETF

0.02%

Fidelity Nasdaq Composite Index ETF

0.01%

Schwab U.S. Broad Market ETF

TrueShares Technology, AI & Deep Learning ETF

占比3.13%

Global X HealthTech ETF

占比1.75%

Fidelity Blue Chip Growth ETF

占比0.07%

T Rowe Price Small-Mid Cap ETF

占比0.06%

iShares Health Innovation Active ETF

占比0.02%

Schwab U.S. Small-Cap ETF

占比0.02%

Fidelity Nasdaq Composite Index ETF

占比0.01%

Schwab U.S. Broad Market ETF

占比0%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

类型

比率

暂无数据

公告日期

类型

比率

暂无数据

常见问题

Heartflow Inc的前五大股东是谁？



Heartflow Inc 的前五大股东如下：
Bain Capital Life Sciences Investors, LLC持有股份：12.45M，占总股份比例：14.93%。
HealthCor Partners Management LP持有股份：6.70M，占总股份比例：8.03%。
Wellington Management Company, LLP持有股份：4.41M，占总股份比例：5.29%。
Fidelity Management & Research Company LLC持有股份：3.29M，占总股份比例：3.94%。
Capricorn Investment Group LLC持有股份：3.92M，占总股份比例：4.70%。